61.
Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Eve...
by Drury, P. L
Diabetologia, 2010-07-30, Vol.54 (1), p.32-43
62.
Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study
by Imai, E
Diabetologia, 2011-10-13, Vol.54 (12), p.2978-2986
63.
Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Ins...
by Mellbin, L. G
Diabetologia, 2011-02-26, Vol.54 (6), p.1308-1317
64.
The association of ulceration of the foot with cardiovascular and all-cause mortality in patients with diabetes: a meta-analysis
by Brownrigg, J. R. W
Diabetologia, 2012-08-14, Vol.55 (11), p.2906-2912
65.
Death, end-stage renal disease and renal function decline in patients with diabetic nephropathy in French cohorts of type 1 and type 2 diabetes
by Hadjadj, Samy
Diabetologia, 2015-10-20, Vol.59 (1), p.208-216
66.
Inpatient Glycemic Variability and Long-Term Mortality in Hospitalized Patients with Type 2 Diabetes
by Timmons, Joseph G
Journal of diabetes and its complications, 2016, Vol.31 (2), p.479-482
67.
Sulfonylurea in combination with insulin is associated with increased mortality compared with a combination of insulin and metformin in a retrospective Danish nationwide study
by Mogensen, Ulrik M
Diabetologia, 2014-09-10, Vol.58 (1), p.50-58
68.
Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database
by Blin, P
Diabetologia, 2012-01-06, Vol.55 (3), p.644-653
69.
The impact of gender on the long-term morbidity and mortality of patients with type 2 diabetes receiving structured personal care: a 13 year follow-up study
by Krag, Marlene Ø
Diabetologia, 2015-11-26, Vol.59 (2), p.275-285
70.
Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomes
by Lettino, Maddalena
European heart journal. Cardiovascular pharmacotherapy, 2017-10-01, Vol.3 (4), p.198-213
71.
Mortality and Other Important Diabetes-Related Outcomes With Insulin vs Other Antihyperglycemic Therapies in Type 2 Diabetes
by Currie, Craig J
The journal of clinical endocrinology and metabolism, 2013-02, Vol.98 (2), p.668-677
72.
A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68)
by CLARKE, P. M
Diabetologia, 2004, Vol.47 (10), p.1747-1759
73.
The cardiovascular safety trials of DPP-4 inhibitors, GLP-1 agonists, and SGLT2 inhibitors
by Secrest, Matthew H
Trends in cardiovascular medicine, 2017, Vol.27 (3), p.194-202
74.
75.
Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study
by Andersson, C
Diabetologia, 2010-09-14, Vol.53 (12), p.2546-2553
76.
Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes
by Resl, M
Heart (British Cardiac Society), 2016-12, Vol.102 (24), p.1963-1968
77.
Toe–brachial index as a predictor of cardiovascular disease and all-cause mortality in people with type 2 diabetes and microalbuminuria
by Zobel, Emilie H
Diabetologia, 2017-07-05, Vol.60 (10), p.1883-1891
78.
ANGPTL2 is associated with an increased risk of cardiovascular events and death in diabetic patients
by Gellen, Barnabas
Diabetologia, 2016-08-04, Vol.59 (11), p.2321-2330
79.
Cardiovascular events and all-cause mortality with insulin versus glucagon-like peptide-1 analogue in type 2 diabetes
by Anyanwagu, Uchenna
Heart (British Cardiac Society), 2016-10-01, Vol.102 (19), p.1581-1587
80.
Geographic variation in Medicare spending and mortality for diabetic patients with foot ulcers and amputations
by Sargen, Michael R
Journal of diabetes and its complications, 2013, Vol.27 (2), p.128-133
